Roche Holding AG
RHHBY
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,605
Roche Holding AG News & Analysis
stocks
10 best US blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks
The 10 best global companies to invest in now
These undervalued stocks of high-quality companies are attractive investments today.
stocks
5 top US dividend shares from the best managers
These cheap dividend stocks are popular among highly rated concentrated fund managers.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,756.70 | 55.20 | -0.63% |
CAC 40 | 8,209.07 | 19.94 | 0.24% |
DAX 40 | 22,817.07 | 18.98 | 0.08% |
Dow JONES (US) | 44,546.08 | 165.35 | -0.37% |
FTSE 100 | 8,782.57 | 14.56 | 0.17% |
HKSE | 22,976.81 | 360.58 | 1.59% |
NASDAQ | 20,026.77 | 81.13 | 0.41% |
Nikkei 225 | 39,270.40 | 96.15 | 0.25% |
NZX 50 Index | 13,051.12 | 17.81 | -0.14% |
S&P 500 | 6,114.63 | 0.44 | -0.01% |
S&P/ASX 200 | 8,481.00 | 56.10 | -0.66% |
SSE Composite Index | 3,324.49 | 31.34 | -0.93% |